Bessemer Group Inc Cytokinetics Inc Transaction History
Bessemer Group Inc
- $60.7 Billion
- Q3 2024
A detailed history of Bessemer Group Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 1,932 shares of CYTK stock, worth $100,502. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,932
Previous 1,216
58.88%
Holding current value
$100,502
Previous $66,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
410Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$763 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$612 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$504 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$404 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$336 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.9B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...